James D. Watson, PhD, whose co-discovery of the twisted-ladder structure of DNA in 1953 helped light the long fuse on a ...

Patients with HER2-positive advanced breast cancers had the greatest benefits, with survival improvements ranging from ...

A patient with transthyretin amyloidosis (ATTR) who received the investigational gene therapy nexiguran ziclumeran (nex-z) in ...

The new guidelines mandate that immigrants' health be a focus in the application process. The guidance applies to nearly all ...

Over 3.5 years, patients randomized to 4 g of daily fish oil had a 43% lower risk for a composite of serious cardiovascular ...

NEW ORLEANS -- Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic ...

Children and adolescents had higher risks of vascular and inflammatory diseases after a first COVID diagnosis, as well as a ...

Republican and Democratic senators were deeply divided at a hearing Thursday over what changes, if any, are needed to improve ...

Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...

The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple ...

For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...

Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall ...